Skip to main content
Equibles
TRLV logo

TRLV · Trulieve Cannabis Corp. · Metrics

Track TRLV — free

Use TRLV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TRLV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.31 -0.01 (-0.09%) At close · Sep 11
Rebalance outlook locked
Market Cap
$2.18B
Shares
192.57M

TRLV metrics

73 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.31
Market cap
$2.18B

Price action

20 metrics
Price change (1W)
-5.6%
Price change (30D)
+17.9%
Price change (3M)
-2.0%
Price change (6M)
+83.5%
Price change (YTD)
+30.3%
Price change (1Y)
+53.2%
Trailing year
Price change (5Y)
-55.2%
52-week high
$13.00
52-week low
$4.76
Change from 52-week high
-12.9%
Change from 52-week low
+137.8%
Annualized volatility
113.7%
Annualized volatility (3M)
65.6%
Beta
1.1
RSI (14D)
56.3
Price vs SMA 50
+16.7%
Price vs SMA 200
+38.2%
Avg volume (3M)
1.38M
Relative volume
1.4
Average dollar volume
$13.63M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
192.57M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 51.7%
P / book
2.9
reciprocal yield 34.8%
FCF yield
9.2%
TTM · current market cap
Buyback yield
—
P / FCF
10.9
reciprocal yield 9.2%
P / operating cash flow
9.0
reciprocal yield 11.1%
Earnings yield
-21.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.2×
reciprocal yield 81.4%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 66.1%
EV / EBIT historical average (3Y)
11.1×
reciprocal yield 9.0%
EV / EBIT historical average (5Y)
22.0×
reciprocal yield 4.5%
EV / EBITDA historical average (3Y)
6.4×
reciprocal yield 15.7%
EV / EBITDA historical average (5Y)
8.6×
reciprocal yield 11.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
59.5%
Operating margin
-24.3%
Trailing 12 months
Net margin
-41.8%
Gross profit (TTM)
$677.39M
Operating profit (TTM)
−$277.26M
Net income (TTM)
−$476.16M
Trailing 12 months
Diluted EPS (TTM)
$-0.79
FCF margin
17.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.98

Growth

11 metrics
Revenue growth YoY
-10.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.14B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
-1.0%
Revenue CAGR (5Y)
+17.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-62.2%
Return on assets
-22.9%
Debt / equity
—
Current ratio
5.9
EBITDA (TTM)
−$162.92M
Free cash flow (TTM)
$202.56M
Quick ratio
4.0
Interest coverage
-4.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$325.42M
Total assets
$2.08B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$244.44M
Capital expenditures (TTM)
$41.88M
R&D (TTM)
—
SG&A (TTM)
$431.99M
Stock compensation (TTM)
$20.81M
R&D / revenue
—
Stock compensation / revenue
1.8%

Ownership (13F)

3 metrics
13F filers
126
13F filer change QoQ
+120
Institutional ownership
18.2%

Short interest

3 metrics
Short interest
0.8%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
54 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$14.66M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1754195 CUSIP 89788C104 13F (30d) 49 filings 49 filers Visit website